tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Brandon Couillard, 119 are a BUY (78.29%), 32 are a HOLD (21.05%), 1 are a SELL (0.66%).
Analyst Brandon Couillard, currently employed at WELLS FARGO, carries an average stock price target met ratio of 67.18% that have a potential upside of 18.2% achieved within 153 days. Previously, Brandon Couillard worked at JEFFERIES.
Brandon Couillard’s has documented 323 price targets and ratings displayed on 25 stocks. The coverage is on Healthcare, Basic Materials, Technology, Industrials sectors.
Most recent stock forecast was given on MYGN, Myriad Genetics at 08-May-2025.
Analyst best performing recommendations are on CDNA (CAREDX).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 10/31/2017. The price target of $60 was fulfilled within 7 days with a profit of $5.01 (9.11%) receiving and performance score of 13.02.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$155
$39.2 (33.85%)
$165
16 days ago
(28-May-2025)
7/10 (70%)
$41.72 (36.83%)
276
Buy
$140
$24.2 (20.90%)
$159
23 days ago
(21-May-2025)
9/16 (56.25%)
$30.32 (27.64%)
112
Hold
$116
$0.2 (0.17%)
$155
1 months 24 days ago
(20-Apr-2025)
14/20 (70%)
$15.74 (15.70%)
386
Hold
$115
$-0.8 (-0.69%)
$145
2 months 4 days ago
(09-Apr-2025)
12/13 (92.31%)
$15.05 (15.06%)
134
Hold
$150
$34.2 (29.53%)
$147
6 months 1 days ago
(12-Dec-2024)
8/8 (100%)
$11.26 (8.12%)
89
Which stock is Brandon Couillard is most bullish on?
Which stock is Brandon Couillard is most reserved on?
What Year was the first public recommendation made by Brandon Couillard?
